Trial Profile
Compassionate Use of Metreleptin in Previously-Treated Patients With Generalized Lipodystrophy
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Metreleptin (Primary)
- Indications Lipodystrophy
- Focus Therapeutic Use
- 26 Feb 2022 Status changed from active, no longer recruiting to recruiting.
- 25 Mar 2021 Status changed from recruiting to active, no longer recruiting.
- 23 Mar 2021 Results (n=11) presented at the 103rd Annual Meeting of the Endocrine Society